Chemical and Pharmaceutical Bulletin p. 777 - 782 (1995)
Update date:2022-08-05
Topics:
Saito
Harada
Nishida
Inouye
Kubo
Treatment of (-)-saframycin A (1a) with selenium oxide in acetic acid afforded (-)-saframycin G (1g), and a catalytic reduction and regioselective oxidation sequence afforded the saframycin Mx type compound (3). We applied this methodology to the transformation of (±)-5-hydroxysaframycin B (11) to the hydroquinone (1e). Acetylation of 1e with acetic anhydride in pyridine gave the triacetate (13), which is identical with the triacetyl derivative of natural saframycin E.
View MoreTaizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Contact:+86-838-5655598
Address:Guanghan Nanfeng Industrial Zone
ZHANGJIAGANG FREE TRADE ZONE YONG HAN INTERNATIONAL TRADING CO., LTD(expird)
Contact:86 512 57910558
Address:qianjin M road
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Shanghai Bojing Chemical Co., Ltd.
Contact:021-37122233
Address:6F Buildiing 11,No.388,Baifu Road,District Fengxian.Shanghai, China.
Doi:10.1016/j.tetasy.2014.04.001
(2014)Doi:10.1021/ol501301w
(2014)Doi:10.1021/acs.jmedchem.7b00592
(2017)Doi:10.1039/c4gc00273c
(2014)Doi:10.1016/j.bmc.2018.05.045
(2018)Doi:10.1016/j.bioorg.2021.104965
(2021)
